Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel
mRNA technology is currently being investigated for a range of oncology indications. We assessed the willingness to pay (WTP) of the general population in Israel for a hypothetical novel mRNA-based treatment f...